Dr. Sarkis Kiramijyan, MD

Dr. Kiramijyan practices at Saint Gregory Heart and Vascular Center, Inc. in Glendale, California.

Dr. Kiramijyan's NPI, 1780841510, was assigned on May 20, 2008. Dr. Kiramijyan graduated from George Washington University School of Medicine and Health Sciences in 2008. Dr. Kiramijyan's Connecticut license number on file is 55932.

Dr. Kiramijyan's primary practice is Saint Gregory Heart and Vascular Center, Inc., at 1560 E Chevy Chase Dr, Glendale, CA 91206 in Los Angeles County. The practice phone is (800) 626-2468.

Dr. Kiramijyan's primary practice is Saint Gregory Heart and Vascular Center, Inc. in Glendale, California. Dr. Kiramijyan is also affiliated with Adventist Health Glendale. The medical group on file is Adventist Health Glendale. Dmand AI also links Dr. Kiramijyan to 4 more hospitals, 2 group practices and clinics, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kiramijyan practices, 8 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Kiramijyan's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Kiramijyan is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Kiramijyan's licenses on file in 3 states: Connecticut, California and District of Columbia.

Dmand AI lists angioplasty, cardiac catheterization, endocarditis and leg revascularization among the conditions Dr. Kiramijyan treats.

CMS data shows 9,005 Medicare services from Dr. Kiramijyan across 41 procedure codes in 2024, for 1,010 Medicare patients. Medicare paid $739,951 for them.

CMS counts 1,010 Medicare patients who saw Dr. Kiramijyan in 2024. The largest group is 65 to 74, with 494 patients. 75% of them have arthritis, and 75% have high blood pressure. 84% are also on Medicaid. Their average risk score is 2.01, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kiramijyan's median patient age at 66, with 49% women.

In 2024, Dr. Kiramijyan wrote 17,752 Medicare Part D claims for 784 patients. 74% of them were for generic drugs. CMS names the drug for 17,454 of them, across 95 drugs with 11 or more claims each, at $3,067,662 in total drug cost. In 2023, CMS named 11,035 claims across 75 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Kiramijyan for performance year 2024, reported individually. Dr. Kiramijyan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 78 procedures of coronary angioplasty and stenting by Dr. Kiramijyan, more than 93% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 46 papers to Dr. Kiramijyan, published from 2012 to 2022. 2016 was the busiest year, with 19. The most frequent topics are Aortic Valve Stenosis, Transcatheter Aortic Valve Replacement and Aortic Valve. Dr. Kiramijyan has published most often in Am J Cardiol. Dr. Kiramijyan's most frequent co-authors are Ron Waksman, MD, Edward Koifman and Lowell Franklin Satler, MD.

CMS Open Payments shows 786 general payments to Dr. Kiramijyan from 58 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 50% of the total. Medtronic Vascular, Inc. paid the most, $17,768.

Dr. Kiramijyan graduated from George Washington University School of Medicine and Health Sciences in 2008. Dr. Kiramijyan is a member of ACC, ACP, AHA, AMA, Armenian American Medical Society (AAMS) and SCAI.

Dr. Kiramijyan is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.